Image of Brunel interior ceiling

Stroke Research Current Studies

ELAN

Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, randomised controlled, two-arm, assessor-blinded trial

The ELAN trial aims to estimate the net benefit of early versus late (current standard practice) initiation of direct oral anticoagulants (DOACs) in patients with acute ischaemic stroke related to atrial fibrillation.

Lead Site: University Hospital Bern, Switzerland

Principle Investigator: Dr Ben Grimshaw

End date: 01/02/2021

Further information can be found about this study. 

The following studies are currently paused due to COVID-19:

HABIT

HABIT Study Logo

The Hemianopia Activity Based InTervention (HABIT): refining and operationalising a rehabilitation intervention for visual field loss after stroke. 

Led by Dr Philip Clatworthy, this study aims to produce a treatment for loss of vision after stroke in adults that can be used in NHS services from early hospital-based rehabilitation to rehabilitation and care at home.

Host Site: North Bristol NHS Trust

Chief Investigator: Dr Phil Clatworthy

Trial Manager: Hannah Sheridan

End date: 12/11/2021

Email habitresearchstudy@nbt.nhs.uk

For more information on HABIT study. 

ICONS II

ICONS II is a randomised controlled trial to compare the effectiveness and cost-effectiveness of a systematic voiding programme with usual care in reducing the severity of urinary incontinence in patients with stroke.

Lead Site: University of Central Lancashire

Principle Investigators: Dr Phil Clatworthy & Kerry Smith

End date: 31/05/2020

Further information can be found about this study.